Verition Fund Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Verition Fund Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,010	Closed	-$651K	–	2811
2023 Q2	$651K	Buy	+14,010	New	+$484K	0.01%	1085

Verition Fund Management's DICE Position: Q3 2023 in Review

Verition Fund Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 14,010 shares — an estimated $651K sold.

Verition Fund Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $651K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Verition Fund Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Verition Fund Management sold 14,010 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $651K.
Verition Fund Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Verition Fund Management's DICE Therapeutics, Inc. Common Stock position peaked at $651K in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Verition Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.